Strauss Borrelli PLLC, a leading data breach law firm, is investigating Amgen, Inc., regarding its recent data breach. The Amgen data breach may have involved sensitive personal identifiable information and protected health information belonging to an undetermined number of individuals.
ABOUT AMGEN, INC.:
Amgen is a biotechnology research company based in California. Founded in 1980, Amgen discovers, develops, and manufactures medicines to treat a wide range of diseases and conditions. Amgen’s investment in research and development has yielded a robust pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.3 Today, Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and is also part of the Nasdaq-100 Index®, which includes the largest non-financial companies listed on the Nasdaq Stock Market based on market capitalization.3 Headquartered in Thousand Oaks, California, Amgen has locations across the world and employs over 10,000 individuals.
WHAT HAPPENED?
Recently, Amgen reported to the Attorney General of California that it had experienced a data breach in which sensitive personal identifiable information and protected health information may have been accessed and acquired. According to the breach notice, Amgen recently learned that one of its third-party service providers, Sirva, Inc., had experienced a data security incident that impacted data belonging to Amgen. On or about September 29, 2023, Sirva became aware of suspicious activity within its network environment. As a result, Sirva launched an investigation to determine the nature of the incident.
Through its investigation, Sirva learned that sensitive personal information in its systems may have been viewed and copied by unknown actors between August 16, 2023, and October 17, 2023. As a result, Sirva began a review of the data to determine what information had been impacted as well as identify the specific individuals affected. On August 8, 2024, Sirva informed Amgen that some of its information may have been impacted in the breach. While the information impacted varies depending on the individual, the type of information potentially exposed includes:
- Name
- Social Security number
- Contact information
- Date of birth
- Non-U.S. address
- Gender identification
- Financial account information
- Credit/debit card information
- Employment information, including salary
- Passport information
- Unique or other government issued ID number
- Taxpayer identification number
- Sirva file number
- Loan information
- Medical/health information
On September 25, 2024, Amgen began mailing data breach notification letters to impacted individuals. Based on the breach notice sent to California residents, Amgen is providing affected individuals with a list of the specific type of sensitive information impacted and complimentary credit monitoring services. A link to the form breach notification letter that Amgen filed with the Attorney General of California is below.
If you received a breach notification letter from Amgen, Inc. or Sirva, Inc.:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at 872.263.1100 or sam@straussborrelli.com.
